Concepedia

Michele Baccarani

MB

Statistics

Publications

507

Citations

52.1K

H-Index

104

Active since

1972

Affiliations

University of Bologna(Current)

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

University of Udine

The University of Texas MD Anderson Cancer Center

Istituto Oncologico Romagnolo

Michele Baccarani is an author at University of Bologna specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1972–2022

507

Publications

507

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.5K citations · Full text

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine · 2010 · 1.6K citations

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus, Richard A. Larson, François Guilhot et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

1–5 of 507